Previous Close | 0.7857 |
Open | 0.8055 |
Bid | 0.8587 x 900 |
Ask | 0.8840 x 2200 |
Day's Range | 0.7510 - 0.8095 |
52 Week Range | 0.7320 - 6.8700 |
Volume | |
Avg. Volume | 4,803,653 |
Market Cap | 114.51M |
Beta (5Y Monthly) | 2.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.8900 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.22 |
Subscribe to Yahoo Finance Plus to view Fair Value for MCRB
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now. To skip our detailed analysis of current stock market news, you can go directly to see the 5 Oversold NASDAQ Stocks To Buy Right Now. NASDAQ Leads The Market On March 12, the Nasdaq Composite Index was […]
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Oversold Healthcare Stocks To Buy Right Now. The Healthcare Sector: The New 2024 Idea? The healthcare sector has been popular […]
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript March 5, 2024 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.4. MCRB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, good morning. My […]